Leptospira kirschneri serovar antigens (L. kirschneri antigens)

Leptospira kirschneri serovar antigens refer to the diverse collection of surface-exposed molecules, including lipopolysaccharides (LPS) and outer membrane proteins (OMPs), that characterize the pathogenic spirochete Leptospira kirschneri (Adler & de la Peña Moctezuma, 2010). These antigens, such as the highly conserved LipL32 and the variable O-antigen of the LPS, are critical for the bacterium's ability to adhere to host tissues and evade the immune system during infection (Picardeau, 2017). In clinical settings, these antigens are the primary targets for diagnostic assays like the Microscopic Agglutination Test (MAT), which remains the gold standard for serotyping and diagnosing leptospirosis (Levett, 2001). While the disease is primarily managed with antibiotics like doxycycline and penicillin that target bacterial ribosomes and cell wall synthesis, the antigens themselves are the focus of vaccine development (Haake & Matsunaga, 2010). A major challenge in targeting these antigens is the significant structural variation between different serovars, which often limits the effectiveness of vaccines to specific strains. Consequently, current research is directed toward identifying conserved protein antigens that could provide broader, cross-protective immunity against multiple Leptospira species (Picardeau, 2017). These antigens also play a role in the induction of the Jarisch-Herxheimer reaction, a systemic inflammatory response that can occur shortly after starting antibiotic treatment for spirochetal infections (Levett, 2001).

Other names

Leptospira kirschneri surface antigensL. kirschneri LPSL. kirschneri outer membrane proteinsLeptospira kirschneri serovar-specific antigens

Vaccine-induced production of agglutinating antibodies that promote bacterial opsonization and clearance (Adler & de la Peña Moctezuma, 2010); Antibiotic-mediated disruption of bacterial cellular processes such as protein synthesis and cell wall integrity (Levett, 2001).